237 related articles for article (PubMed ID: 34035856)
1. Portal vein thrombosis: A concise review (Review).
Costache RS; Dragomirică AS; Dumitraș EA; Mariana J; Căruntu A; Popescu A; Costache DO
Exp Ther Med; 2021 Jul; 22(1):759. PubMed ID: 34035856
[TBL] [Abstract][Full Text] [Related]
2. Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review.
Gupta S; Hidalgo J; Singh B; Iyer A; Yang Y; Short A; Singh S; Bhatt H; Gupta S
Cureus; 2021 Aug; 13(8):e16922. PubMed ID: 34367844
[TBL] [Abstract][Full Text] [Related]
3. Portal Vein Thrombosis in Cirrhosis.
Shukla A; Giri S
J Clin Exp Hepatol; 2022; 12(3):965-979. PubMed ID: 35677518
[TBL] [Abstract][Full Text] [Related]
4. Management of splanchnic vein thrombosis.
Elkrief L; Payancé A; Plessier A; d'Alteroche L; Ronot M; Paradis V; Valla D; Rautou PE
JHEP Rep; 2023 Apr; 5(4):100667. PubMed ID: 36941824
[TBL] [Abstract][Full Text] [Related]
5. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.
Rugivarodom M; Charatcharoenwitthaya P
J Clin Transl Hepatol; 2020 Dec; 8(4):432-444. PubMed ID: 33447527
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis.
Primignani M; Tosetti G; La Mura V
World J Hepatol; 2015 Dec; 7(29):2906-12. PubMed ID: 26689354
[TBL] [Abstract][Full Text] [Related]
8. Management of Chronic Portal Vein Thrombosis in a Cirrhotic Patient With Pancytopenia and Grade II Esophageal Varices.
Aziz AA; Yang D; Naeem M; Christmas D
Cureus; 2022 Jan; 14(1):e21150. PubMed ID: 35165600
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis.
Ai MH; Dong WG; Tan XP; Xu L; Xu C; Zhang Q; Zhang Y; Li J
Eur J Gastroenterol Hepatol; 2020 Oct; 32(10):1395-1400. PubMed ID: 32675774
[TBL] [Abstract][Full Text] [Related]
10. Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
Weinberg EM; Palecki J; Reddy KR
Semin Liver Dis; 2019 May; 39(2):195-208. PubMed ID: 30978730
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician.
Basili S; Pastori D; Raparelli V; Violi F
Therap Adv Gastroenterol; 2018; 11():1756284818793561. PubMed ID: 30202445
[TBL] [Abstract][Full Text] [Related]
13. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
Loffredo L; Pastori D; Farcomeni A; Violi F
Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T
Wien Klin Wochenschr; 2018 Jul; 130(13-14):446-455. PubMed ID: 29916054
[TBL] [Abstract][Full Text] [Related]
15. Vascular liver disorders (II): portal vein thrombosis.
Hoekstra J; Janssen HL
Neth J Med; 2009 Feb; 67(2):46-53. PubMed ID: 19299846
[TBL] [Abstract][Full Text] [Related]
16. [Correlational study on portal vein thrombosis of liver cirrhosis].
Xu DQ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):573-579. PubMed ID: 32791792
[No Abstract] [Full Text] [Related]
17. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
[TBL] [Abstract][Full Text] [Related]
19. Portal vein thrombosis in cirrhosis.
Raja K; Jacob M; Asthana S
J Clin Exp Hepatol; 2014 Dec; 4(4):320-31. PubMed ID: 25755579
[TBL] [Abstract][Full Text] [Related]
20. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate.
Faccia M; Ainora ME; Ponziani FR; Riccardi L; Garcovich M; Gasbarrini A; Pompili M; Zocco MA
World J Gastroenterol; 2019 Aug; 25(31):4437-4451. PubMed ID: 31496623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
